[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"infection-wound\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:infection-wound":69},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,44],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":4,"eligibilityCriteria":13,"healthyVolunteers":10,"sex":14,"minAge":15,"maxAge":4,"enrollmentInfo":16,"targetDuration":4,"studyType":19,"phases":20,"briefSummary":22,"conditions":23,"keywords":26,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100562801",false,"NCT06607887","The Role of Postoperative Antibiotics in Laparoscopic Cholecystectomy","Inclusion Criteria:\n\n* Adult patients (aged above 18 years) undergoing laparoscopic cholecystectomy.\n\nExclusion Criteria:\n\n* patients with comorbidities (Diabetes, malignancies, Immunosuppressed). Lost of follow-up. Patients received antibiotics within 72 hr before admission. Complicated cases involved, gangrenous and perforated cholecystitis and abscess.","ALL","18 Years",{"count":17,"type":18},300,"ESTIMATED","INTERVENTIONAL",[21],"PHASE4","Comparison between postoperative parenteral prophylactic antibiotics, and oral antibiotics regarding the incidence of post laparoscopic cholecystectomy infection.",[24,25],"Infection Wound","Antibiotic Resistant Infection",[27,28,29,30],"antibiotic","prophylaxis","cholecystectomy","postoperative","RECRUITING","2024-09-19",{"date":34,"type":35},"2024-09-23","ACTUAL",{"date":37,"type":35},"2024-08-30",{"date":39,"type":18},"2024-12-30",{"name":41,"class":42},"Minia University Hospital","OTHER",1,{"id":45,"slug":4,"hasResults":10,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":10,"sex":14,"minAge":4,"maxAge":4,"enrollmentInfo":49,"targetDuration":4,"studyType":51,"phases":4,"briefSummary":52,"conditions":53,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":43},"100451068","NCT05153694","Infectious Complications After Cystectomy: A Prospective Observational Study","Inclusion Criteria:\n\n* Disease which requires removal of the urinary bladder\n\nExclusion Criteria:\n\n* Patient does not want to participate",{"count":50,"type":18},200,"OBSERVATIONAL","Patients undergoing cystectomy for either oncological or non-oncological indications are prospectively enrolled following informed consent. This study design incorporates a comprehensive medical history, detailed prospective documentation of clinicopathological parameters, and serial measurements of infectious markers pre- and post-operatively. In-hospital complications are meticulously recorded, and long-term outcomes assessed through structured follow-up interviews at 3, 6, and 12 months. These follow-ups utilize standardized questionnaires to evaluate post-discharge infectious complications and gather patients' perspectives on their in-hospital experiences, providing a robust understanding of both clinical outcomes and patient-reported experiences.",[54,55,56,57,24,58,59,60],"Bladder Cancer","Infections","Infection, Bacterial","Infection, Hospital","Urinary Tract Infections","Urinary Bladder Diseases","Urinary Tract Disease","2024-09-13",{"date":32,"type":35},{"date":64,"type":35},"2021-12-01",{"date":66,"type":18},"2025-12-31",{"name":68,"class":42},"Ludwig-Maximilians - University of Munich",""]